Literature DB >> 8393239

Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons.

J K Fazakerley1, S Pathak, M Scallan, S Amor, H Dyson.   

Abstract

In neonatal mice the A7(74) and L10 strains of Semliki Forest virus (SFV) are virulent. In 3- to 4-week-old mice the L10 strain is virulent, the A7(74) strain is avirulent. Following intraperitoneal inoculation of 3- to 4-week-old mice both strains produce a transient plasma viremia. This is cleared by IgM antibodies. IgG antibodies of all subclasses are produced. The distribution of viral RNA in the brain as determined by autoradiographic analysis of in situ hybridizations shows that in all cases virus is first apparent as small foci of infected cells around cerebral capillaries. In both neonatal and 3- to 4-week-old mice infected with L10 or neonatal mice infected with A7(74), infection spreads rapidly from the original foci to infect large areas throughout the brain. Both neurons and glial cells are infected resulting in pycnosis and death of the animals. In the brains of 3- to 4-week-old mice infected with A7(74) virus there is little spread from the original perivascular foci. Again neurons and oligodendrocytes are infected but cellular destruction is minimal. The same pattern of A7(74) infection is observed in 3- to 4-week-old athymic nu/nu mice and mice with severe combined immunodeficiency, indicating that failure to spread is not related to specific immune responses. Furthermore, in nu/nu and SCID mice the small restricted foci of A7(74) infection persist. Comparison of the replication of these two viruses by electronmicroscopy shows that although A7(74) virus replicates completely in the neurons of neonatal mice, the virus is unable to bud from the neurons of 3- to 4-week-old mice and aggregates of viral RNA and capsid accumulate. We conclude that there is an age-related restriction of A7(74) replication in mouse neurons and that this restriction is not associated with the maturity of virus-specific immune responses but probably reflects age-related changes in neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393239     DOI: 10.1006/viro.1993.1414

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Specific infection and destruction of dopaminergic neurons in the substantia nigra by Theiler's virus.

Authors:  K R Oliver; P Brennan; J K Fazakerley
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Pseudo-typed Semliki Forest virus delivers EGFP into neurons.

Authors:  Fan Jia; Huan Miao; Xutao Zhu; Fuqiang Xu
Journal:  J Neurovirol       Date:  2016-10-13       Impact factor: 2.643

4.  Replicase complex genes of Semliki Forest virus confer lethal neurovirulence.

Authors:  M T Tuittila; M G Santagati; M Röyttä; J A Määttä; A E Hinkkanen
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis.

Authors:  A Bridgen; F Weber; J K Fazakerley; R M Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 6.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 7.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

8.  PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response.

Authors:  Gerald Barry; Lucy Breakwell; Rennos Fragkoudis; Ghassem Attarzadeh-Yazdi; Julio Rodriguez-Andres; Alain Kohl; John K Fazakerley
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

9.  Attenuation of Semliki Forest virus neurovirulence by microRNA-mediated detargeting.

Authors:  Erkko Ylösmäki; Miika Martikainen; Ari Hinkkanen; Kalle Saksela
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

10.  Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice.

Authors:  Jari E Heikkilä; Markus J V Vähä-Koskela; Janne J Ruotsalainen; Miika W Martikainen; Marianne M Stanford; J Andrea McCart; John C Bell; Ari E Hinkkanen
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.